Literature DB >> 12848811

Relationship between ST-segment morphology and conduction disturbances detected by signal-averaged electrocardiography in Brugada syndrome.

Mitsuaki Takami1, Takanori Ikeda, Yoshihisa Enjoji, Kaoru Sugi.   

Abstract

BACKGROUND: Although arrhythmogenesis of Brugada syndrome is still unknown, it has been reported to be associated with conduction disturbances. Two ST-segment morphologies (coved and saddle-back patterns) have been described in this syndrome. No study has sought to determine which morphology has stronger conduction disturbances, thereby associating with life-threatening events.
METHODS: Forty-six patients who presented the Brugada-type ECG with either of a characteristic coved (n = 25) or saddle-back (n = 21) pattern of ST-segment morphology underwent signal-averaged ECG (SAECG). SAECG parameters, and the history of life-threatening events defined as syncope or aborted sudden death, were compared between groups.
RESULTS: Although filtered QRS duration did not differ between groups, the incidence of late potentials in the coved group was higher than in the saddle-back group (22 patients (88%) versus 4 patients (19%); P < 0.01), showing lower RMS40 and longer LAS40. Life-threatening events occurred in 17 patients (68%) in the coved group and 7 patients (33%) in the saddle-back group (P = 0.02).
CONCLUSION: The coved pattern of ST segment was more closely related to conduction disturbances than the saddle-back pattern in patients with Brugada-type ECG. Life-threatening events were more common in patients with the coved ST-segment elevation. Conduction disturbances in the coved pattern of ST segment may reflect a substrate of arrhythmogenesis in Brugada syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 12848811      PMCID: PMC6932588          DOI: 10.1046/j.1542-474x.2003.08106.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  26 in total

1.  Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G).

Authors:  G Baroudi; V Pouliot; I Denjoy; P Guicheney; A Shrier; M Chahine
Journal:  Circ Res       Date:  2001-06-22       Impact factor: 17.367

2.  Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms.

Authors:  I Gussak; C Antzelevitch
Journal:  J Electrocardiol       Date:  2000-10       Impact factor: 1.438

3.  Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.

Authors:  Ghayath Baroudi; Said Acharfi; Chantal Larouche; Mohamed Chahine
Journal:  Circ Res       Date:  2002-01-11       Impact factor: 17.367

4.  Lack of an association between T-wave alternans and ST-segment depression during exercise-induced ambulatory ischemia.

Authors:  T Ikeda; K Kumagai; M Takami; N Tezuka; T Nakae; T Sakata; M Noro; Y Enjoji; K Sugi; T Yamaguchi
Journal:  J Electrocardiol       Date:  2000-07       Impact factor: 1.438

5.  Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.

Authors:  Josep Brugada; Ramon Brugada; Charles Antzelevitch; Jeffrey Towbin; Koonlawee Nademanee; Pedro Brugada
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

6.  Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Idiopathic Ventricular Fibrillation Investigators.

Authors:  H Atarashi; S Ogawa; K Harumi; H Hayakawa; T Sugimoto; R Okada; M Murayama; J Toyama
Journal:  Am J Cardiol       Date:  1996-09-01       Impact factor: 2.778

7.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.

Authors:  Q Chen; G E Kirsch; D Zhang; R Brugada; J Brugada; P Brugada; D Potenza; A Moya; M Borggrefe; G Breithardt; R Ortiz-Lopez; Z Wang; C Antzelevitch; R E O'Brien; E Schulze-Bahr; M T Keating; J A Towbin; Q Wang
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

8.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors:  G X Yan; C Antzelevitch
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

9.  Familial sudden cardiac death associated with a terminal QRS abnormality on surface 12-lead electrocardiogram in the index case.

Authors:  A Garg; W Finneran; G K Feld
Journal:  J Cardiovasc Electrophysiol       Date:  1998-06

10.  Natural history of Brugada syndrome: insights for risk stratification and management.

Authors:  Silvia G Priori; Carlo Napolitano; Maurizio Gasparini; Carlo Pappone; Paolo Della Bella; Umberto Giordano; Raffaella Bloise; Carla Giustetto; Roberto De Nardis; Massimiliano Grillo; Elena Ronchetti; Giovanna Faggiano; Janni Nastoli
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

View more
  4 in total

Review 1.  Electroanatomic voltage mapping and characterisation imaging for "right ventricle arrhythmic syndromes" beyond the arrhythmia definition: a comprehensive review.

Authors:  Franco Zoppo; Giulia Gagno; Luca Perazza; Andrea Cocciolo; Giacomo Mugnai; Diego Vaccari; Vittorio Calzolari
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-24       Impact factor: 2.357

2.  A review of the mechanisms of ventricular arrhythmia in brugada syndrome.

Authors:  J Bhar-Amato; Lm Nunn; Pd Lambiase
Journal:  Indian Pacing Electrophysiol J       Date:  2010-09-05

3.  Atrial electrical abnormality in patients with Brugada syndrome assessed by signal-averaged electrocardiography.

Authors:  Yasutsugu Nagamoto; Yuto Fujii; Yuichi Morita; Yusuke Ueda; Yasuko Miyake; Kenichi Yamane; Mai Fujiwara; Shinji Mito; Yuichiro Watari; Hiromichi Tamekiyo; Tomokazu Okimoto; Yuji Muraoka; Yasuhiko Hayashi
Journal:  Indian Heart J       Date:  2017-05-23

Review 4.  SCN5A Variants: Association With Cardiac Disorders.

Authors:  Wenjia Li; Lei Yin; Cheng Shen; Kai Hu; Junbo Ge; Aijun Sun
Journal:  Front Physiol       Date:  2018-10-09       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.